miR-195 was shown to be markedly downregulated in HCC, and restoring the expression of miR-195 enabled it to regain its tumor suppressive function by affecting NF-κB downstream effectors by way of directly targeting IKKα and TAB3 at the post-transcriptional level (32). The gene discussed is TAB3; the disease is hepatocellular carcinoma.